- Dividend Yield
- 4.15%
- Annual Dividend Payout
- $0.48
- Earnings Per Share
- $0.04
- Payout Ratio
- 1,200.0%
- Consensus Rating
- Sell
- Consensus Price Target
- $11.00 (6.6% Downside)
About Viatris
Viatris Inc operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health.
Read More
